Is Fructose Linked to Adiposity in Babies? (FLAB)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01262781|
Recruitment Status : Completed
First Posted : December 17, 2010
Last Update Posted : April 10, 2014
|Condition or disease|
|Obesity Metabolic Syndrome|
The "fetal origins hypothesis" suggests that an individual's risk for obesity and metabolic disorders begins in utero; that fetal or early postnatal exposure to environmental factors, such as maternal nutrition or endocrine disrupting chemicals, adversely influences early development and results in permanent changes affecting energy storage and expenditure.
Most studies on "fetal origins" of obesity in the offspring have focused on maternal high-fat diets; yet dietary fat consumption has not changed appreciably in the last two decades. One chemical exposure in both pregnant mothers and newborns that has been steadily increasing worldwide is fructose. Although ostensibly a carbohydrate, fructose is a potent lipogenic substrate, and in the hypercaloric state, as much as 30% of an ingested fructose load undergoes de novo lipogenesis to form triglyceride thus the effects of high-fat and high-fructose diets in terms of physiology and outcome are comparable. Substituting sucrose (fructose + glucose) for glucose alone increases visceral adiposity, insulin resistance, and dyslipidemia in adult animals and humans. For humans, fructose is ubiquitous in the food environment, especially for pregnant mothers, who are often counseled to drink juice during pregnancy, as it is deemed to be healthier than soda. The effects of fructose consumption during pregnancy on infant birth weight and adiposity has not yet been studied.
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Is Fructose Linked to Adiposity in Babies?|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||January 2013|
- % adiposity (DEXA) [ Time Frame: After delivery, neonatal adiposity will be measured using DEXA. This part of the protocol takes place 4-5 months after recruitment. ]After delivery, neonatal adiposity will be measured using DEXA.
- cord blood insulin (corrected by cord blood glucose) [ Time Frame: At delivery (in the OR): 4-5 months after recruitment ]
- cord blood triglycerides [ Time Frame: At delivery (in the OR): 4-5 months after recruitment ]
- cord blood leptin [ Time Frame: At delivery (in the OR): 4-5 months after recruitment ]
- anthropometric measurements on the newborn [ Time Frame: After delivery (4-5 months after recruitement) ]birth weight, arm, thigh, and abdominal circumference, subscapular skinfolds
- fetal fractional thigh volume obtained by fetal ultrasound [ Time Frame: At 32 weeks gestation (4 months after recruitment) ]The fetal fractional thigh volume will me measured in addition to routine fetal measurements at 32 weeks estimated gestation age. This measurement is a measure of neonatal adiposity.
- cord blood uric acid [ Time Frame: At delivery (in the OR): 4-5 months after recruitment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01262781
|United States, California|
|San Francisco General Hospital|
|San Francisco, California, United States, 94110|
|Principal Investigator:||Robert Lustig, MD||University of California, San Francisco|
|Study Director:||Anjali Jain, MD||University of California, San Francisco|